Trials / Completed
CompletedNCT05866887
Insomnia Prevention in Children With Acute Lymphoblastic Leukemia
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 25 (actual)
- Sponsor
- Dana-Farber Cancer Institute · Academic / Other
- Sex
- All
- Age
- 4 Years – 12 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this research study is to understand the acceptability and feasibility of the Sleep ALL Night intervention among children with Acute Lymphoblastic Leukemia (ALL) in hopes of improving the discussion of sleep disorders with clinical providers. The name of the intervention used in this research study is: Sleep ALL Night, which is a sleep intervention program comprised of an action plan tool and psychoeducational website.
Detailed description
This research study is to conduct a single-arm pilot study to determine the acceptability and feasibility of Sleep ALL Night for children with Acute Lymphoblastic Leukemia (ALL). Participation in this research study is expected to last 1 month. It is expected about 30 children will take part in this research study. The National Cancer Institute (NCI) is providing funding for this research study through a grant.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Sleep ALL Night | Sleep intervention program comprised of a sleep action plan tool and interactive psychoeducation website. |
Timeline
- Start date
- 2023-09-26
- Primary completion
- 2024-06-05
- Completion
- 2024-06-05
- First posted
- 2023-05-19
- Last updated
- 2025-06-06
- Results posted
- 2025-06-06
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT05866887. Inclusion in this directory is not an endorsement.